Role of the extracellular cAMP-adenosine pathway in renal physiology

American Journal of Physiology - Renal Physiology

Volumn 281, Issue 4 50-4, 2001, Pages

  Jackson, Edwin K ^a   Dubey, Raghvendra K ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Adenosine receptors; cAMP egress; Ecto 5 nucleotidase; Kidney; Phosphodiesterase; Vascular smooth muscle

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE RECEPTOR; ADENYLATE CYCLASE; CYCLIC AMP; PHOSPHODIESTERASE; RENIN;

BIOSYNTHESIS; CAPILLARY RESISTANCE; CELL GROWTH; CELL LEVEL; ENZYME ACTIVATION; GLOMERULUS FILTRATION RATE; HORMONAL REGULATION; HUMAN; KIDNEY FUNCTION; MEMBRANE TRANSPORT; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; RENIN RELEASE; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0034795730     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.281.4.f597     Document Type: Review

References (148)

1. 2-receptor agonists on intrarenal blood flow
2. Isolated superfused juxtaglomerular cells from rat kidney: A model for study of renin secretion
3. Role of adenosine in the renal responses to contrast medium
4. A potential role for endogenous adenosine in control of human glomerular and tubular function
5. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man
6. The quantitative relationship between intracellular concentration and egress of cyclic AMP from cultured cells
7. The egress of cyclic AMP from metazoan cells
8. Hypertonic NaCl enhances adenosine release and hormonal cAMP production in mouse thick ascending limb
9. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
10. Caffeine potentiates the renin response to diazoxide in man. Evidence for a regulatory role of endogenous adenosine
11. The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus
12. Extrusion of cyclic AMP from pigeon erythrocytes
13. 1 receptor antagonist, on sodium-dependent phosphate and glucose transport by the rat renal proximal tubular cell
14. 1 receptor antagonist, is mediated by cyclic adenosine monophosphate
15. The effect of theophylline and cyclic adenosine 3′,5′-monophosphate on renin release by afferent arterioles
16. Recent advances in the molecular biology of nucleoside transporters of mammalian cells
17. Adenosine stimulates phosphate and glucose transport in opossum kidney epithelial cells
18. Release of cyclic AMP from rat superior cervical ganglia after stimulation of synthesis in vitro
19. Adenosine, an endogenous anti-inflammatory agent
20. Adenosine receptors: Selective agonists and antagonists
21. The effect of L-epinephrine and other agents on the synthesis and release of adenosine 3′,5′-phosphate by whole pigeon erythrocytes
22. Adenosine inhibits β-adrenoceptor but not DBcAMP-induced renin release
23. Methylxanthines augment the renin response to suprarenal-aortic constriction
24. Adenosine inhibits renin release induced by suprarenal aortic constriction and prostacyclin
25. Contribution of S-adenosylhomocysteine to cardiac adenosine formation
26. Regulation of adenosine 3′,5′-monophosphate efflux from rat glioma cells in culture
27. Cyclic. AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells
28. 2B receptors
29. 2B receptors
30. Adenosine inhibits collagen and total protein synthesis in vascular smooth muscle cells
31. Cyclic AMP-adenosine pathway inhibits glomerular mesangial cell growth
32. 2b receptors
33. 2B receptors
34. Cardiac fibroblasts express the cyclic AMP-adenosine pathway
35. Endogenous cyclic AMP-adenosine pathway regulates cardiac fibroblast growth
36. Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway
37. Smooth muscle cell-derived adenosine inhibits cell growth
38. 2b receptor
39. 2B receptors mediate antimitogenesis in vascular smooth muscle cells
40. 2B receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts
41. Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth
42. Prevention of radiocontrast-induced nephropathy by adenosine antagonists in rats with chronic nitric oxide deficiency
43. Cyclic AMP efflux is regulated by occupancy of the adenosine receptor in pig aortic smooth muscle cells
44. Characterization of cyclic AMP efflux from swine adipocytes in vitro
45. Cellular and molecular biology of chloride secretion in the shark rectal gland: Regulation by adenosine receptors
46. Mechanisms whereby extracellular adenosine 3′,5′-monophosphate inhibits phosphate transport in cultured opossum kidney cells and in rat kidney. Physiological implication
47. Exocytosis and endocytosis in juxtaglomerular cells
48. The hydrolysis of extracellular adenine nucleotides by arterial smooth muscle cells. Regulation of adenosine production at the cell surface
49. The hydrolysis of extracellular adenine nucleotides by cultured endothelial cells from pig aorta. Feed-forward inhibition of adenosine production at the cell surface
50. Extracellular metabolism of cyclic AMP
51. 1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure
52. Morphology, physiology, and molecular biology of renin secretion
53. Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement
54. Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney
55. Renovascular effects of adenosine receptor agonists
56. Metabolism of cAMP to adenosine: Role in vasodilation of rat pial artery in response to hypotension
57. P2 receptors in regulation of renal microvascular function
58. Adenosine: A physiological brake on renin release
59. Renal actions of purines
60. P1 and P2 receptors in the renal system
61. The preglomerular microcirculation expresses the cAMP-adenosine pathway
62. Metabolism of cAMP to adenosine in the renal vasculature
63. The selective response to adenosine of renal microvessels from hamster explants
64. Effects of parathyroid hormone on plasma and urinary adenosine 3′,5′-monophosphate in man
65. Beta-adrenergic stimulation of adenine nucleotide catabolism and purine release in human adipocytes
66. Nephrotoxicity from contrast media: Attenuation with theophylline
67. Amelioration of glycerol-induced acute renal failure in the rat with 8-cyclopentyl-1,3-dipropylxanthine
68. The effects of epinephrine and prostaglandin E-1 on cyclic adenosine 3′,5′-monophosphate levels in WI-38 fibroblasts
69. Inhibition of egress of adenosine 3′,5′-monophosphate from pigeon erthrocytes
70. Amelioration of cisplatin-induced acute renal failure with 8-cyclopentyl-1,3-dipropylxanthine
71. 1 receptor blockade in normotensive and spontaneously hypertensive rats: Role of pertussis toxin-sensitive G-proteins
72. Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart
73. Adenylyl cyclase amino acid sequence: Possible channel- or transporter-like structure
74. 1 adenosine receptors
75. Endogenous adenosine restrains renin release during sodium restriction
76. Endogenous adenosine restrains renin release in conscious rats
77. Cellular control of renin secretion
78. Effects of hormones on cyclic AMP release in perfused rat livers
79. Conditions for augmentation of renin release by theophylline
80. The role of members of the pertussis toxin-sensitive family of G proteins in coupling receptors to the activation of the G protein-gated inwardly rectifying potassium channel
81. Distribution and regulation of renal ecto-5′-nucleotidase: Implications for physiological functions of adenosine
82. 2 production, adenine nucleotide release, and responses to vasoactive agents
83. 2 receptor
84. 2 receptor
85. The transmethylation pathway as a source for adenosine in the isolated guinea-pig heart
86. 3-Isobutyl-1-methylxanthine decreases renal cortical interstitial levels of adenosine and inosine
87. Metabolism of exogenous cyclic AMP to adenosine in the rat kidney
88. Evidence for an endogenous cAMP-adenosine pathway in the rat kidney
89. Effects of α- and β-adrenoceptor blockade on purine secretion induced by sympathetic nerve stimulation in the rat kidney
90. Adenosine production in the ischemic kidney
91. Primary structure of rat liver 5′-nucleotidase deduced from the cDNA. Presence of the COOH-terminal hydrophobic domain for possible post-translational modification by glycophospholipid
92. 1 receptor blockade on glomerular hemodynamics: Involvement of renin-angiotensin system
93. Effects of adenosine receptor agonists in the isolated, perfused rat kidney
94. Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists
95. 1-receptor antagonist, against cisplatin-induced acute renal failure in rats
96. 1-receptor antagonist, on cephaloridine-induced acute renal failure in rats
97. 2A receptors on renal microvascular reactivity
98. 2 receptor
99. The release of adenosine 3′,5′ cyclic monophosphate from the isolated perfused rat heart
100. 2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney
101. The role of receptor structure in determining adenosine receptor activity
102. Efflux of cyclic adenosine monophosphate from cells: Mechanisms and physiological implications. Biochemistry (Moscow)
103. Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischemic recirculation
104. Intrarenal blood flow: Microvascular anatomy and the regulation of medullary perfusion
105. Further characterization of the protective effect of 8-cyclopentyl-1,3-dipropylxanthine on glycerol-induced acute renal failure in the rat
106. Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine
107. Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture
108. Characterization of eetonucleotidases on vascular smooth-muscle cells
109. Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides
110. The effects of cyclic adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate and theophylline on renin secretion in the isolated perfused kidney of the rat
111. 1 receptor antagonism augments β-adrenergic-induced renin release in vivo
112. Increased sensitivity of the renal vasculature to adenosine in streptozotocin-induced diabetes mellitus rats
113. Role of 5′-nucleotidase in adenosine-mediated renal vasoconstriction during hypoxia
114. Stimulation of renin secretion in dogs by theophylline
115. Regulation of adenosne 3′:5′-monophosphate efflux from animal cells
116. Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture
117. β-Adrenergic receptor-mediated regulation of extracellular adensoine in cerebral cortex in culture
118. Vasoactive intestinal peptide regulates extracellular adenosine levels in rat cortical cultures
119. Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by β-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex
120. Forskolin evokes extracellular adenosine accumulation in rat cortical cultures
121. A possible purinergic mechanism for reactive ischemia in isolated, cross-circulated rat kidney
122. Formation and metabolism of adenosine and adenine nucleotides in cardiac tissue
123. Extracellular nucleotide signaling along the renal epithelium
124. 1 antagonist with renal protective and diuretic activities
125. Adenosine modulates vasomotor tone in outer medullary descending vasa recta of the rat
126. Sodium intake markedly alters renal interstitial fluid adenosine
127. Hormonally sensitive cyclic AMP phosphodiesterase in liver cells. An ecto-enzyme
128. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions
129. 1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure
130. Effects of adenosine compounds on renal function and renin secretion in dogs
131. 1 receptor
132. Adenosine formed by 5′-nucleotidase mediates tubuloglomerular feedback
133. Caffeine potentiates vasodilator-induced renin release
134. 1A receptor-deficient mice
135. Effect of caffeine treatment on plasma renin activity and angiotensin I concentrations in rats on a low sodium diet
136. Natriuretic and hypotensive effect of adenosine-1 blockade in essential hypertension
137. Renin stimulation by isoproterenol and theophylline in the isolated perfused kidney
138. Synergistic effects of angiotensin and adenosine in the renal microvasculature
139. 1 receptor antagonist
140. i/o fusion proteins
141. 1-receptor antagonist, against gentamicin-induced acute renal failure in rats
142. Cyclic AMP metabolism by swine adipocyte microsomal and plasma membranes
143. 5′-Nucleotidase: Molecular structure and functional aspects
144. Ecto-nucleotidases
145. Role of renal medullary adenosine in the control of blood flow and sodium excretion
146. Effect of chronic salt loading on adenosine metabolism and receptor expression in renal cortex and medulla in rats
147. Effects of hormones on cyclic AMP release from rat adipose tissue in vitro